Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Coho Relative Value Equity 2023 Q4 Investor Letter | Buyside Digest

Back to Fund Profile (Coho Relative Value Equity)

Primary Source Intelligence • Q4 2023 Letter Analysis

Coho Relative Value Equity Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Coho Relative Value Equity. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

QTD+9.9%

YTD+3.1%

Positioning StanceConstructive

Market CapLarge Cap

GeographyUS

Digest Analysis

Quick Take

"3% for the S&P 500. Valuation discipline and sector positioning in Healthcare and Consumer Staples created headwinds against narrow tech leadership."

Executive Summary

Coho Relative Value Equity delivered disappointing 2023 performance, returning 3.1% versus 26.3% for the S&P 500, as AI euphoria drove narrow market leadership concentrated in the Magnificent 7 stocks. The portfolio's valuation discipline and overweight positions in Health Care and Consumer Staples created headwinds when multiple expansion dominated returns over fundamentals. GLP-1 obesity drug concerns particularly impacted food holdings like ConAgra and Smucker, while Dollar General was the largest individual detractor due to supply chain issues under new management. The manager upgraded portfolio positioning in Q4, eliminating weaker positions like Baxter and Smucker while adding to high-conviction names including Abbott Labs, Medtronic, Nike, ThermoFisher, Disney, and Microchip Technologies. Despite 2023 challenges, the portfolio companies continued delivering consistent fundamentals, and valuations remain attractive relative to benchmarks. Looking ahead, the manager maintains conviction in their quality-focused, valuation-disciplined approach, expecting better participation if markets broaden and strong downside protection during any decline. Historical patterns suggest concentrated market leadership often reverses, supporting their patient, contrarian positioning.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

68%

CautiousHigh

Moderate (68%)

Manager demonstrates high conviction through specific position sizing decisions, naming individual holdings with clear rationales, and maintaining philosophy despite underperformance. Detailed discussion of Dollar General additions, specific reasons for eliminating Baxter and Smucker, and explicit conviction in long-term approach indicate strong belief in strategy. However, diversified portfolio approach and acknowledgment of multiple scenarios prevents maximum conviction score.

Growth Outlook

38%

BearishBullish

Neutral (38%)

Manager expresses caution about 2024 with multiple unknowns including rate cuts, geopolitics, and elections. Historical analysis suggests concentrated market returns often lead to difficult following years, with only one positive outcome in four previous instances. Charts showing soft landing discussions preceding recessions and tightening cycles leading to recessions indicate underlying concern about market conditions.

Risk Appetite

10%

DefensiveAggressive

Defensive (10%)

Portfolio positioning shows modest risk-on bias through Q4 additions to high-conviction names and elimination of weaker positions. Manager upgraded portfolio quality by adding to Medtronic, Nike, ThermoFisher, Disney, and Microchip while trimming outperformers. However, overall approach remains defensive with emphasis on downside protection and valuation discipline.

Capital Deployment

25%

De-riskingDeploying

De-risking (25%)

Moderate deployment activity in Q4 with elimination of two positions (Baxter, Smucker) and additions to six high-conviction names (Abbott, Medtronic, Nike, ThermoFisher, Disney, Microchip, Dollar General). Manager describes being more active in Q4 to upgrade portfolio risk/reward profile. No specific cash level changes mentioned, but trading activity suggests modest net deployment bias.

Forward Guidance

0%

CautiousExpansionary

Cautious (0%)

Manager takes balanced approach to deployment, expressing readiness to participate if markets continue higher while maintaining defensive positioning for potential declines. No clear directional bias toward aggressive deployment or defensive positioning, instead emphasizing optionality and maintaining current disciplined approach.

Language Signal

45%

BearishBullish

Balanced (45%)

Language contains more risk-focused terms including recession warnings, bubble comparisons to 1999 and 2007, and multiple references to uncertainty and unknowns. While some opportunity language exists around attractive valuations and portfolio positioning, the overall tone leans slightly toward caution and risk awareness rather than bullish optimism.

Perceived Risk

72%

Low RiskElevated

Elevated Risk (72%)

Manager identifies multiple specific systemic risks including historical patterns showing concentrated market returns leading to poor following-year performance, recession risks from tightening cycles, and numerous macro uncertainties. Detailed charts and analysis of bubble-like conditions in 1999 and 2007 demonstrate significant concern about current market environment and potential downside scenarios.

Opportunity Density

35%

ScarceAbundant

Selective (35%)

Manager describes limited opportunity set due to narrow market breadth and lofty valuations, noting only 23% of stocks in their Coho 250 universe outperformed the S&P 500. Emphasis on selectivity and difficulty finding attractively priced opportunities, though some selective additions were made in Q4 to high-conviction names where market underappreciates long-term potential.

Time Horizon

75%

Short-TermLong-Term

Decade+ (75%)

Manager emphasizes long-term approach with 24-year track record and commitment to philosophy despite short-term underperformance. Focus on companies with consistent long-term fundamentals and willingness to hold through volatility, as demonstrated with Dollar General position. Forward 10-year return analysis and emphasis on patient capital approach indicate multi-year investment horizon.